logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Malignant Neoplasm Of Breast

    FiltersReset Filters
    36 results

    • abraxane

      (Paclitaxel)
      Abraxis BioScience, LLC
      Usage: ABRAXANE is indicated for treating metastatic breast cancer after chemotherapy failure, as well as for first-line treatment of locally advanced or metastatic non-small cell lung cancer in combination with carboplatin. It is also indicated for first-line treatment of metastatic pancreatic adenocarcinoma combined with gemcitabine.

    • anastrozole

      (Anastrozole Tablets)
      Avet Pharmaceuticals Inc
      Usage: Anastrozole is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer, and second-line treatment for advanced breast cancer in patients with disease progression after tamoxifen therapy.

    • anastrozole

      (Anastrozole)
      Chartwell RX, LLC
      Usage: Anastrozole is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced/metastatic breast cancer, and as second-line treatment for advanced breast cancer following tamoxifen therapy.

    • anastrozole

      (Anastrozole Tablets)
      Yiling Pharmaceutical, Inc.
      Usage: Anastrozole is indicated for postmenopausal women with hormone receptor-positive early breast cancer as adjuvant treatment, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer. It is also used as second-line therapy after tamoxifen failure in advanced cases.

    • arimidex

      (Anastrozole)
      ANI Pharmaceuticals, Inc.
      Usage: ARIMIDEX is indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatment of hormone receptor-positive or unknown locally advanced and metastatic breast cancer, particularly after disease progression on tamoxifen therapy.

    • aromasin

      (exemestane)
      Pharmacia & Upjohn Company LLC
      Usage: AROMASIN is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer after two to three years of tamoxifen therapy, and for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen.

    • capecitabine

      (Capecitabine)
      Ascend Laboratories, LLC
      Usage: Capecitabine is indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal, advanced or metastatic breast cancer, unresectable or metastatic gastric, esophageal, gastroesophageal junction cancers, and for adjuvant treatment of pancreatic adenocarcinoma as part of combination chemotherapy regimens.

    • cerianna

      (FLUOROESTRADIOL F 18)
      GE Healthcare Inc.
      Usage: CERIANNA is indicated for use with PET imaging to detect estrogen receptor-positive lesions in patients with recurrent or metastatic breast cancer. It serves as an adjunct to biopsy, but its efficacy does not extend to other receptors like HER2 or progesterone receptor. Tissue biopsy is necessary for confirmation.

    • cyclophosphamide

      (Cyclophosphamide)
      NorthStar RxLLC
      Usage: Cyclophosphamide for injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to corticosteroids.

    • cyclophosphamide

      (cyclophosphamide)
      Baxter Healthcare Corporation
      Usage: Cyclophosphamide for Injection is indicated for treating various malignancies in adults and pediatric patients, including malignant lymphomas, multiple myeloma, leukemias, and specific cancers like breast and ovarian carcinoma. It's also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy fails.